HSOA Stock Overview
Provides post-acute healthcare services in the United States and Puerto Rico. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Encompass Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$88.00 |
| 52 Week High | US$99.00 |
| 52 Week Low | US$60.00 |
| Beta | 0.77 |
| 1 Month Change | -6.88% |
| 3 Month Change | 2.33% |
| 1 Year Change | 46.67% |
| 3 Year Change | 49.15% |
| 5 Year Change | 45.45% |
| Change since IPO | 273.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSOA | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -1.7% | 0.8% | 0.3% |
| 1Y | 46.7% | 18.1% | 6.9% |
Return vs Industry: HSOA exceeded the German Healthcare industry which returned 18% over the past year.
Return vs Market: HSOA exceeded the German Market which returned 7.2% over the past year.
Price Volatility
| HSOA volatility | |
|---|---|
| HSOA Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: HSOA has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HSOA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 27,481 | Mark Tarr | www.encompasshealth.com |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Encompass Health Corporation Fundamentals Summary
| HSOA fundamental statistics | |
|---|---|
| Market cap | €9.07b |
| Earnings (TTM) | €414.84m |
| Revenue (TTM) | €5.01b |
21.6x
P/E Ratio1.8x
P/S RatioIs HSOA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSOA income statement (TTM) | |
|---|---|
| Revenue | US$5.22b |
| Cost of Revenue | US$3.06b |
| Gross Profit | US$2.16b |
| Other Expenses | US$1.73b |
| Earnings | US$431.50m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.28 |
| Gross Margin | 41.40% |
| Net Profit Margin | 8.27% |
| Debt/Equity Ratio | 82.7% |
How did HSOA perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield14%
Payout RatioDoes HSOA pay a reliable dividends?
See HSOA dividend history and benchmarks| Encompass Health dividend dates | |
|---|---|
| Ex Dividend Date | Jan 02 2025 |
| Dividend Pay Date | Jan 15 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 15 days |
Does HSOA pay a reliable dividends?
See HSOA dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 06:02 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Encompass Health Corporation is covered by 36 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null RESEARCH DEPARTMENT | Avondale Partners |
| Matthew Gillmor | Baird |
| Ishan Majumdar | Baptista Research |